Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 26, 2025 20:30 ET | Source: GENENTA SCIENCE SPA

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
October 24, 2025 04:00 ET | Source: GENENTA SCIENCE SPA

Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production

GENENTA AND ANEMOCYTE ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE OFF-THE-SHELF LVV PLASMID DNA PRODUCTION
July 01, 2025 05:00 ET | Source: GENENTA SCIENCE SPA

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
May 07, 2025 07:00 ET | Source: GENENTA SCIENCE SPA; Anemocyte

Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies

Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell based therapies
April 15, 2025 05:00 ET | Source: GENENTA SCIENCE SPA

Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar

CEO Genenta Science (Nasdaq: GNTA) will present at “Montalcini Global Biotech Tour Doha April 17, 2025
March 19, 2025 09:28 ET | Source: GENENTA SCIENCE SPA

Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates

Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
January 09, 2025 06:00 ET | Source: GENENTA SCIENCE SPA

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
October 23, 2024 07:00 ET | Source: GENENTA SCIENCE SPA

Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”

Genenta’s CEO to present at the U.S. Senate, Washington D.C.at the meeting “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatl
October 02, 2024 06:30 ET | Source: GENENTA SCIENCE SPA

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer

Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
May 06, 2024 06:25 ET | Source: GENENTA SCIENCE SPA

Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power...